Cargando…
CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies
In the past decade, the emergence of chimeric antigen receptor (CAR) T-cell therapy has led to a cellular immunotherapy revolution against various cancers. Although CAR-T cell therapies have demonstrated remarkable efficacy for patients with certain B cell driven hematological malignancies, further...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557333/ https://www.ncbi.nlm.nih.gov/pubmed/36248810 http://dx.doi.org/10.3389/fimmu.2022.1019115 |